Journal of cachexia, sarcopenia and muscle
The open access journal for wasting syndromes: the muscle and weight loss that accompanies advanced cancer and other chronic diseases. Read by oncologists, geriatricians, nutrition scientists and muscle biologists.
Overview
The Journal of Cachexia, Sarcopenia and Muscle is published by Wiley on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders, which describes it as a peer-reviewed international journal dedicated to publishing both research and clinical materials related to cachexia and sarcopenia from all fields of the life sciences. NLM catalogues it from 2010 as a quarterly, first published in Germany, indexed for MEDLINE under Cachexia, Muscles and Sarcopenia. The Directory of Open Access Journals lists it as fully open access since 2010 under a CC BY licence, with anonymous peer review and an article processing charge.
Pages like this
not linked directly; found by shared links- TechnologyHydrazine sulfate
Shares Cachexia-directed therapy (GDF-15 blockade), Cancer cachexia.
- TechnologyFish oil (EPA) for cancer weight loss
Shares Cachexia-directed therapy (GDF-15 blockade), Cancer cachexia.
- TrialROMANA 1 and ROMANA 2
Shares Cachexia-directed therapy (GDF-15 blockade), Cancer cachexia.
- TrialPonsegromab phase 2 in cancer cachexia
Shares Cachexia-directed therapy (GDF-15 blockade), Cancer cachexia.
- TechnologyResistance training and protein for cachexia and sarcopenia
Shares Cachexia-directed therapy (GDF-15 blockade), Cancer cachexia.
- TechnologyCachexia pharmacotherapy: GDF-15 blockade, anamorelin, olanzapine
Shares Cachexia-directed therapy (GDF-15 blockade), Cancer cachexia.